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Arumugam Nagalingam1, Jack L. Arbiser2, Michael Y. Bonner2, Neeraj K. Saxena3 and Dipali Sharma1*Erratum
After the publication of this work [1], an error was
noticed in Fig. 1b. An incorrect image was inadvertently
shown for the soft-agar colony for MDA-MB-231 cells
treated with 5.0 uM Honokiol. The correct figure is
shown below. This error did not affect the findings or
conclusions of the article.
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Fig. 1 Honokiol inhibits clonogenicity and anchorage-independent growth of breast cancer cells. a MCF7 and MDA-MB-231 cells were treated
with various concentrations of honokiol (HNK) (as indicated) and subjected to clonogenicity assay. Untreated cells, denoted with the letter “U”.
Colonies containing >50 normal-appearing cells were counted. *, P < 0.005, compared with untreated controls. b Breast cancer cells were
subjected to soft-agar colony-formation assay in the presence of various concentrations of honokiol for three weeks. Untreated cells are denoted with
the letter “U”. Results are expressed as average number of colonies counted (in six micro-fields). *, P < 0.001, compared with untreated controls
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